Phase II Study to Examine Precision Radiation in Patients With Pathogenic Mutations in ATM
This study is testing if a lower dose of radiation therapy can successfully treat cancer that has spread to other parts of the body. Researchers want to find out if using less radiation can still help manage symptoms for people who have a specific genetic change called an ATM mutation.
You may be able to join if you are 18 or older, have cancer that has spread and needs radiation for symptom relief, and have a confirmed ATM genetic change. You must also be able to perform your normal daily activities and not have received prior conflicting radiation to the same area.
Participants will receive a carefully measured, reduced dose of radiation therapy aimed at shrinking tumors and relieving pain or other symptoms. Doctors will monitor you closely to see how well the lower dose works while protecting your healthy tissue.
This study is currently recruiting participants at three locations in New Jersey, United States: Basking Ridge, Middletown, and Montvale.
- 1Testing if lower doses of radiation are effective for cancer with an ATM gene mutation
- 2Aims to relieve cancer symptoms while minimizing side effects
- 3Currently recruiting patients at multiple locations in New Jersey
No related links yet
Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.
Suggest a linkThis summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.